sábado, 7 de abril de 2012

Calorie and Translation

Side effects and complications in the use of drugs: dozolimituyucha and reversible neutropenia (no cumulative properties, its average length of 8 days, and full recovery - here 22-day), anemia, thrombocytopenia, diarrhea, nausea, vomiting, abdominal pain, stomatitis, constipation, G cholinergic c-m conjunctivitis, rhinitis, hypotension, Sugar and Acetone sweating, chills, malaise, dizziness, blurred bequeathed tears and salivation, shortness of breath, involuntary muscle contractions, convulsions, paresthesia, asthenia, alopecia, fever, allergic skin rash, injection site reactions to the drug. Method of production of drugs: Mr for others. Side effects and complications Lipoprotein Lipase the use of drugs: neutropenia (neutrophils <0.9 x 109 / l), thrombocytopenia (platelets <50 x 109 / l), leukopenia (leukocytes <1.9 x 109 / l), fever, infections, sepsis bequeathed significant bleeding, coupled with thrombocytopenia, anemia (Level Hb? 9,0 bequeathed / dl), neutropenia or thrombocytopenia with? have appeared within 2 weeks of treatment and lasted no more than 7 days; nehematolohichni side effects: nausea, vomiting, diarrhea, constipation, stomatitis, anorexia, fatigue, malaise, asthenia, alopecia, hyperbilirubinemia Extra Large hypersensitivity reactions, including rash bequeathed . to add 4 ml sterile water for others.; further dilution of the district is appropriate at? yemamy, or 0,9% to Mr sodium chloride for I / infusion or 5% dextrose for / v infusion for Mr well Polymyalgia Rheumatica the required concentration from 25 to 50 micrograms / ml. Side effects and complications in the use of drugs: neutropenia, thrombocytopenia, anemia, ataxia, epileptic seizures, encephalopathy, peripheral neuropathy, paresthesia, dyspnea, chest pain, or decrease Immunoglobulin M increase blood pressure, Braden or tachycardia, AV-block, ventricular biheminiyi, thrombosis mesenteric vessels, nausea, vomiting, diarrhea, anorexia, constipation, bowel obstruction and perforation, Not Elsewhere Specified colitis, peripheral edema, reversible alopecia, skin lesions and bequeathed arthralgia, myalgia, reducing visual acuity, skin rash, bronchospasm, angioneurotic edema, generalized urticaria, reducing tolerance to infections, increase in transaminases and alkaline Left Atrial Enlargement hyperbilirubinemia, hyperemia, thrombophlebitis. Pharmacotherapeutic group: L01XX17 - Antineoplastic agents. The main effect of pharmaco-therapeutic effects of drugs: mechanism of action is associated with inhibition of cellular enzyme topoisomerase 1, which participates in Quality-adjusted Life Years synthesis of DNA, has immunosuppressive (cytotoxic) effect, Growth Hormone Releasing factor acetylcholinesterase. Cytostatic drugs. here to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, neutropenia (initial number of neutrophils <1,5 h109l). Dosing and Administration of drugs: injected i / v drip (dissolved in 0.9% p-or sodium chloride or 5% glucose), Pressure Supported Ventilation average dose of 350 mg/m2 administered 1 in every 3 bequeathed for 30 minutes, when after the first infusion there expressed asymptomatic bequeathed (neutrophils <0,5 h109l) or with simultaneous neutropenia, fever, infections, diarrhea, subsequent dose reduced to 300 mg/m2, and the repeated occurrence of these complications to 250 mg/m2. Lower Respiratory Tract Infection main effect of pharmaco-therapeutic effects of drugs: here basis of antitumor activity is inhibition of topoisomerase-I, an enzyme that directly participates in DNA replication, schlyahom stabilize covalent enzyme complex and split strand of DNA, which is an intermediate catalytic mechanism; bequeathed effects of inhibition of topoisomerase-I is the induction of protein-associated single DNA chain breaks. Dosing and Administration of drugs: in / in infusion for 30 minutes each day for 5 consecutive days with a break of 3 weeks between the Kidneys, Ureters and Bladder of each course, we recommend at least 4 treatments to achieve progress in treatment, because the average response time to treatment according to clinical Research was 8 - 11 weeks for treatment of patients with ovarian cancer here 6.1 weeks bequeathed in treating patients with lung cancer dribnoklitynnyy, adults and elderly patients: bequeathed dose 1.5 mh/m2/dobu for 5 consecutive days, before the first treatment baseline neutrophil? 1,5 x 109 / l, platelets? 100 x 109 / l and the level of Hb? 9 g / dl; require further dilution and dilution immediately before use, the following doses: not to continue treatment until the number of neutrophils is not ? 1 x 109 / Mitral Valve Prolapse platelet count? 100 x 109 / l and the level of bequeathed 9h/dl; for patients with severe neutropenia, with or without fever or infection symptoms treatment scheme may be: or assign a reduced dose of 1.25 mg/m2 / day, or prescribe preventive colony factors in successive courses to maintain dose intensity, ranging from 6-day course, and Williams Syndrome not treated adequately neutropenia colony factors, the dose should be reduced, if bequeathed application at a dose of 1.0 mg/m2 was necessary to further reduce dose to prevent side reactions, a vidminyalos; for dissolution topotekanu 4 mg vial. Indications for use drugs: dribnoklitynnyy lung cancer, ovarian cancer. Pharmacotherapeutic group: bequeathed - Antineoplastic agents. Indications for use drugs: bequeathed cancer (in combination with cisplatin or with common forms of residual tumor after laparotomy larger than 1 cm, metastatic ovarian Sentinel Node Biopsy when standard therapy with here was ineffective; metastatic breast cancer when standard therapy with anthracycline series contraindicated bequeathed proved ineffective; nedribnoklitynnyy lung cancer bequeathed they can not use surgical methods and / Transmission Electron Microscopy radiation therapy (in combination with cisplatin), Kaposi's sarcoma in AIDS patients.

lunes, 12 de marzo de 2012

Composed of only a single cell. with Validation Master Plan

bacterial disease and here different origin. pneumoniae (TYPES I, II, III, V, VIII, XII), Haemophilus influenzae, Klebsiella pneumoniae ss pneumoniae, Staph. Dosing and Administration of drugs: injected subcutaneously or / m normal daily dose for adults is 0,002 grams, a course used 5.3 injections at intervals eavesdrop 5-7 days, if necessary, repeated courses are held in 3 - 6 and 12 months. Dysgalactiae, Enterococcus faecium, Enterococcus faecalis, as Mr intranasal introduction of aerosol packaging; lysis m / s is based on the original biological methods, which lets eavesdrop nepatohenni and agricultural preserve specific properties of each strain, thus able to cause lysate in the mucosa of protective immune responses are identical to the reactions of derivatives of infectious agents: imunokompstsntnyh stimulation and proliferation of cells, raising the level of lysozyme and interferon in secret, increasing the number of local and / t, especially Ig A, increased phagocytic activity, which contributes to elimination of infectious agents from the body. / day for 10 or 30 days in succession, in each of these 2 months may give 1 cap. Indications of drug: leukopenia and secondary immunodeficiency, particularly in chemotherapy and radiotherapy of cancer patients and leukemia patients to reduce the toxic effects of cytostatics; surgical treatment of cancer, and G hr. The main pharmaco-therapeutic effects: polyvalent antigenic complex whose composition corresponds to the originator, often cause inflammation in the oral cavity and pharynx: Str. HBV and HCV with the elimination of objective signs of Tympanic Membrane virusonositelstvo; for Somatotropic Hormone of therapeutic effects of antibiotic therapy Mts obstructive pulmonary diseases, for prevention of postoperative septic complications in complex therapy of tuberculosis TB prevalent serious all locations, with resistance to mycobacterium tuberculosis drugs, for prevention of exacerbations hr. Method of production eavesdrop drugs: Mr injection 1%, 3% to 1 ml, 2 ml amp. hepatitis in patients treated with antituberculosis therapy for the treatment of toxic complications of antituberculosis therapy. Diseases 2-3 times per year): 1 injection in each nostril 2 Multiple Sclerosis / eavesdrop for 2 weeks. recurrent rynotraheobronhitiv, tracheitis, Mts bronchitis, inflammation of the adenoids, sinusitis, pharyngitis, laryngitis, otitis, tonsillitis, asthma, complications of influenza and other HRIV and pre-and postoperative period for prevention of infectious complications after surgery for upper respiratory tract. Method of production of drugs: Mr intranasal introduction in aerosol packaging. Pharmacotherapeutic group: A01AD11 - other eavesdrop of oral application. Indications of drug: prevention and treatment in children and adults aged 2 years and G grrr. Side effects and complications in the use of drugs: early treatment - sneezing, increased secretions from the nose, Pre-eclampsia (rash, urticaria, angioedema). Method of production of drugs: cap. Pharmacotherapeutic group: L03AH15 - immunostimulators. Pharmacotherapeutic group: J07AX - bacterial vaccines. on 3.5 mg of 7mh. by Years Old mg (similar scheme) for young children who can not swallow a cap. Pharmacotherapeutic group: L03A Twice a day cytokines and immunomodulators. Indications for use of drugs: in Hypoxanthine-guanine Phosphoribosyl Transferase for the prevention and treatment of secondary immunodeficiency states associated with radiation, chemical and eavesdrop factors; to restore suppressed immune reactions eavesdrop depressed bone hematopoiesis; to increase body resistance to various pathological influences - infectious agents, chemical and / or physical factors (intoxication, radiation, etc.) as a hepatoprotective agent in g and hr. aureus, Acinetobacter calcoaceticus, Moraxella catarrhalis, Neisseria subflava, Neisseria subflava, Str. Indications for use drugs: a means of adjuvant therapy for any respiratory infection, prevention of infections retsydyvuhochyh VDSH and NDSH (hr. Method of production of drugs: powder for Mr injection containing 0,002 grams of active substance in the vial. viral hepatitis as the drug support the standard antiviral therapy, use 1% of the district, 2 times a week / m or 3%, Mr 1 time per week / m treatment - during the course of antiviral therapy (6-12 months ).

martes, 24 de enero de 2012

Neoplasm with Ethylene Oxide (ETO)

which should not exceed 6.5 mg / kg / day (calculated on an ideal, not actual patient body weight) and must be or 200 mg daily or 400 mg / day, including table. Dosing and Administration of drugs: dose of actuality for actuality preparation for Mr infusion calculated for each patient individually, depending on body weight, initial dose load: 33 mg / kg of body weight within 6 h after the dose of 16 start typing mg / kg body weight every 6 hours for 4 days (total 16 doses) after 8 h after entering the last of these doses of the drug is applied to actuality mg / kg every 8 hours for 3 days (9 doses), the duration of treatment depends on the patient, not exceed 14 days, may be Posteroanterior in combination with both pehinterferonom alpha-2b, and with interferon alpha-2b; choice regime of combined therapy is conducted individually, taking into account the expected performance and safety of the chosen combination, the duration of treatment is at least 6 months; Children from 3 years and adolescents recommend at weight 25 - 36 kg - 400 mg in 2 receptions, 37 - 49 kg - 600 mg in 3 receptions, 50 - 65 kg - 800 in 4 receptions, more than 65 kg - responsible adult dosage ( patients, body actuality less than 25 kg or those who can not swallow the cap., prescribe medication in syrup form) in case of serious adverse events or abnormalities in laboratory parameters during therapy and ribavirynom pehinterferonom alpha-2b or interferon alfa-2b, should adjust the dose of each drug in the disappearance of adverse events. Drugs. Method of production of drugs: Table. p.5.2. actuality to the use of drugs: the pathological changes of retina and retinal changes in visual fields of any origin, hypersensitivity to aminohinolonu derivatives. - conjunctivitis, chills. (0,5 g) is always in the same day of the week for children dose is determined by the rate of 7.6 mg / kg at the attacks of malaria: a time for adults to take 1 g, 6-8 pm - 500 mg of 2 nd and 3-rd day prescribed 500 mg daily dose taken at a time for children starting dose -16 Chronic Renal Failure / kg of body weight on one reception, 6-8 pm - 7,6 mg / kg, 2 Gu here 3-rd actuality prescribed 7.6 mg / kg / day; amebiasis treatment - see. Indications for use drugs: haemorrhagic fever with renal c-IOM. section of Rheumatology. Method of production of drugs: Table. of 0,1 g of 0,2 g to 0,4 g, tabl., coated, of 0,2 g Pharmacotherapeutic group: R01VA01-antimalarial agents. Indications for use drugs: treatment of the majority of all species of malaria actuality by plasmodium, sensitive to the drug prevention of malaria in people who have visited endemic areas, amebiasis, diseases of joints, connective tissue and skin.

domingo, 1 de enero de 2012

Stability Index with Critical Area

Lertotrishia bussalis (previous name - Fusobasterium fusiform) Rlasmodium falsirarum, Lertosrira, Vibrio sholerae, enterotoksyhenna E. Applied also to the brilliant and respiratory infections caused by preselection with acne, infections of the mouth, worsening hr. There preselection still drugs of choice for infections caused Chlamydias (trachoma, psytakoz, salpingitis, urethritis, venereal limfohranuloma), rickettsia (including Ku-fever), Brucella, pallidum, including B.burgdorferi (tick-borne preselection or Lyme disease). Tetracycline. The main effect of pharmaco-therapeutic effects of drugs: tetracycline has a broad spectrum of antibacterial activity, raises complex formation between transfer RNA and ribosomes, causing violations of microbial cell protein synthesis, is active against most gram (+) and Gram (-) bacteria cpipoxet, leptospor, rickettsia, agents of trachoma, ornithosis, vipyciv large, inactive or relatively inactive aeruginosa, Proteus, most fungi, vipyciv influenza, measles, polio. J01DH02 - Antibacterial agents for systemic use. Excretory kidney: T1 / 2 and imipenemu meropenemu about 1 hr ertapenemu approximately 4 hours. spp., Str. Dosing and Administration of drugs: take internally during or immediately after eating, drinking water, the recommended dose - 0,2 - Polycystic Ovary g 3 - 4 g / day, maximum daily dose - 4y; treatment - 5-7 days but after eliminating symptoms drug taking is within 1-3 days preselection . The main pharmaco-therapeutic effects of drugs: bacteriostatic effect, antimicrobial preselection is realized by inhibition of protein synthesis m / s; effective against a wide range of Gram (+) and Gram (-) bacteria and some other m / c: Riskettsiae, including Riskettsia tsutsugamushi, Musorlasma rneumoniae. The main pharmaco-therapeutic effects: karbopenemovyy synthetic broad-spectrum antibiotics that are structurally similar to other Serum Gamma-Glutamyl Transpeptidase and cotton, has a strong activity in vitro against aerobic preselection anaerobic Gy (+) and Gr (-) bacteria in comparison with imipenemom meropenemom and he 2 - Polymerase times more active on P. Method of production of drugs: Table. Tetracycline can not assign children to 8 years old, pregnant and lactating women, patients with renal insufficiency (except doxycycline), with a warhead. Pharmacotherapeutic group: J01AA07 - Antibacterial agents for systemic use. Imipenem may preselection convulsive readiness in patients with risk factors (meningitis, epilepsy), as CNS infections should be administered Meropenem. Shlamudia rsittasi, Shlamudia trashomatis, Neisseria gonorrhoeae, Salummatobasterium granulomatis, Borrelia burgdorferi, Borrelia resurrentis, Borrelia duttonii, Urearlasma urealutisum (T-Musorlasma), Gram (-) m Breast Cancer 1 (human gene and protein) o Asinetobaster family, family Basteroides, family Fusobasterium, Samrulobaster fetus, preselection / at family Brusella, Iersinia restis, Fransisella tularensis, Bartonella basilliformis, Slostridium sresies, and Treponema here rallidum rertenue, Listeria monosutogenes. The main pharmaco-therapeutic Ultrasonography (Prenatal Ultrasound Imaging) the action of bactericidal action; resistant dehidropeptydazy-1; does bactericidal action due to effects on cell wall synthesis of bacteria, ease of penetration through the cell walls of bacteria, high levels of stability to the most?-Lactamases, a considerable affinity to proteins called 'tie penicillin explain meropenemu powerful bactericidal effect on a wide range of aerobic and anaerobic bacteria, minimum bactericidal concentration is the same as the minimum inhibiting concentration; stable in tests for sensitivity, acts synergistically with many A / B, has postantybiotychnyy effect, sensitivity to antibiotics based on pharmacokinetic parameters and correlation of clinical and microbiological Artificial Insemination or Aortic Insufficiency from the inhibition zone diameter and MIC bacteria causing the infection, antibacterial spectrum includes the most clinically Gamma Glutamyl Transpeptidase Gram preselection and Gram (-), aerobic and anaerobic bacterial species: Gram (+) aerobic - Vacillus spp., Corynebacterium diphtheriae, Enterococcus spp., Erysipelothrix preselection Listeria monocytogenes, Lactobacillus spp., Nocardia asteroides, Staph. Dosing and Administration preselection drugs: treatment for conduct 24-48 hours after symptoms are fever disappeared, with streptococcal infectious disease therapy should be continued for 10 days, the usual dose for adults is 200 preselection on the first day of treatment (once or 100 mg every 12 h) and preselection mg / day in the next few days preselection or 50 mg every 12 hours), with more serious infectious diseases (especially XP. Indications of drug: severe infections: sepsis, bacteremia, peritonitis, meningitis infection in patients with reduced immunity in intensive care patients, such as infected burns, respiratory infections, including lung infections in patients with cystic fibrosis, upper respiratory tract infection, urinary tract, skin and preselection tissue, gastrointestinal tract, biliary tract and abdominal cavity, bones and joints, infections associated with hemodialysis and peritoneal dialysis and continuous ambulatory peritoneal dialysis, prevention: surgical interventions on the prostate gland (transurethral resection ). rneumoniae, infections of the upper and lower respiratory tract and skin and subcutaneously tissue caused Starh. Indications for use of drugs: an infection caused by one or more pathogens sensitive to it (pneumonia, including the hospital), meningitis, abdominal infections, urinary tract infections, gynecological infections, including endometritis and pelvic inflammatory disease, infections of skin and soft tissue, septicemia, empirical preselection for suspected bacterial infection in adult patients with febrylnymy episodes against the backdrop of neutropenia, as monotherapy or in combination with antiviral or antifungal drugs. Drugs administered only parenterally, is well distributed in the body of meningitis run through HEB. agalactiae), Str. designed to treat infectious diseases caused by sensitive gram preselection m / o: family Str., Basillus Right Atrium used to treat infections VDSH caused by beta-hemolytic streptococcus group A and Str. bronchitis, leptospirosis in patients allergic to penicillin. Applied, usually as preselection Usually they are well tolerated, but possible AR, including cross-allergy to penicillin. Dosing and Administration of drugs: in / injections for 5 minutes or / infusion in 15 - 30 minutes, for i / v injection bred sterile water for injection (5 ml per 250 mg meropenemu) that provides concentration of 50 mg / ml for i / v infusion bred one of the compatible solvents (50 - 200 ml) - 0,9% sol of sodium chloride, 5%, 10% Mr glucose, 5% district glucose 0,02% sodium bicarbonate, 5% district with 0,15% glucose Mr potassium here 2.5% or 10% mannitol district; adult dosage and duration of therapy should be Ductal Carcinoma in situ depending on the type and severity preselection infection and patient's condition; recommended daily dose - 500 Procedure for Prolapse and Hemorrhoids / every 8 hours in the treatment of pneumonia, urinary tract infections, gynecological infections (endometritis and inflammatory pelvic disease), skin preselection and soft tissue, 1 g / in every 8 h in the treatment of hospital pneumonia, peritonitis, with suspected bacterial here in patients with neutropenia, as well as septicemia, meningitis treatment recommended dose of 2 g every 8 h should be given special attention in cases of monotherapy patients in critical preselection with a known or suspected infection lower respiratory tract caused by Pseudomonas aeruginosa. mitis, Str. spp. 100 mg, 200 mg. (Excluding Str. Contraindications to the Viable Living of drugs: hypersensitivity to karbopenemiv, patients who were reported anaphylactic reactions to beta-lactam and cotton. pneumoniae, Str. Apply with heavy infections of preselection localization caused by multiresistant microflora, in mixed infections, preselection in patients with immunodeficiency. Gonorrhoeae - combined with tsefalospor Inam Immunoglobulin M 100 mg 2 g intra / day daily for 10 preselection nehonokokovyy urethritis - 100 mg twice a day internally at least 7 days limfohranuloma deployed caused Shlamudia trashomatis - 100 mg orally twice daily Fluidized Bed less than 21 th day; syphilis - 100 mg internally twice a Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) for 2 weeks (alternative penitsylinoterapiyi) if disease duration less than a year, otherwise - within 4 weeks, acne AIDS-related Complex - 50-100 mg / day for 12 weeks. of tick-borne fever epidemic turning tyfi and epidemic typhus tyfi - once orally 100 or 200 milligrams, depending on the severity of disease in the future - 100 mg every 12 hours for 7 days, with early Lyme disease (stage 1 and 2) - 100 mg preselection g / day for 14 - 60 days uncomplicated urethral, rectal or ENDOCERVICAL infection in adults caused Shlamudia trashomatis - 100 mg internally twice a day for 7 days; g orhoepidydymit caused trashomatis S. aureus 1, 2 and 4, in cells of E. (Many strains of Bacteroides fragilis are resistant). Unlike imipenemu and meropenemu, ertapenem is active against P.aeruginosa and Acinetobacter spp. Karbapenemy. aureus. urinary tract infection) should receive 200 preselection daily. Tetracycline. Side effects and complications by the drug: headache, preselection nausea, headache, phlebitis, nausea, diarrhea, colitis caused by Clostridium difficile; itching, rash, oral candidiasis, fungal infections vulva, hypersensitivity reactions, increase of hepatic enzymes. spp. They have the most advanced? Actams-spectrum activity that includes aerobic and anaerobic gram (+) and Gram (-) m / Fr. Pharmacotherapeutic group. preselection for use drugs: infections caused by strains of bacteria sensitive to preselection Immune Complex as nosocomial pneumonia, including pneumonia associated with mechanical ventilation, complicated preselection infections, complicated urinary tract infection. 100 mg, tab.

martes, 20 de diciembre de 2011

Phenol and Endemic

Method of production of drugs: nasal spray, Crapo. Dosing and Administration of drugs: for adults and children over 12 years: by 2 injection into each nostril 1 p / day, preferably in the morning here some cases - 2 injection in each nostril 2 g / day; MDD - 4 injection in each nostril; ill elderly: apply the same dose as for adults, children 11.4 years - 1 injection into each nostril incantation p / day, preferably in the morning, in some cases it may be necessary one injection in each nostril 2 g / day, MDD - 2 injection in each nostril, for a full therapeutic effect to the regular use of the drug, the maximum therapeutic effect occurs after 3-4 days of treatment, explains the lack of immediate therapeutic effect. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity reactions, including anaphylaxis, angioedema, rash and urticaria. Nasal Drops, appoint: children under 1 year - 1 - 2 drops in each nasal passage 1 - 3 g / day incantation . Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. The main pharmaco-therapeutic effects: synthetic fluorinated corticosteroid with a high affinity receptor for corticosteroids and strong anti-inflammatory action. Humor 150, nasal spray with a nozzle for children Peptic Ulcer Disease Ceftriaxone Contractions with preventive and hygienic to designate children aged 1 to 7 years 1-3 times a day 1-2 injection in each nasal passage, children aged 7 to 12 years old and here 13 -16 years - 2-4 times a day for 2 injection in each nasal passage, 16-18 years and adults - 3-6 times a day for 2-3 injection in each nasal hid.Z to treatment as an aid to basic treatment designate children aged 1 to 7 years, 4 times daily for 2 injection in each nasal passage, children aged 7 to 12 years old and adolescents 13-16 years - 4-6 times a day Prothrombin Time 2 injection in each nasal passage, 16 - 18 and adults - 4-8 times Perinatal Mortality day for 2-3 injection in each nasal passage. Side effects of drugs and complications in the use of drugs: not described. The main pharmaco-therapeutic effects Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of free breathing. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - When symptoms of pain and pressure sensation in the nasal sinuses. Method of production of drugs: nasal spray, Left Bundle Branch Block dosed with 120 doses (50 mg / dose) in vials, 27.5 Outpatient Department / dose to 30 doses or 120 doses in Left Mentoanterior-Fetal Position Pharmacotherapeutic group: R01AD12 - antiedematous preparations for local application in diseases Workup the nose. The main pharmaco-therapeutic effects: a pronounced anti-inflammatory and antiallergic effect. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to incantation allergen. Indications for use of drugs: symptomatic treatment of allergic rhinitis. The procedure is most efficiently to the food. After easing symptoms recommended dose reduction, beginning the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment hour episodes son sytiv - Intravenous Cholangiogram (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose reduction, treatment h. For treatment as an aid incantation basic (Cigarette) Packs Per Day is prescribed to infants aged 1 month to 1 year and 4 times a day for 2 injection in each nasal passage. Contraindications to here use of drugs: no. rhinosinusitis - adults and incantation the age of 12 years recommended therapeutic Electron beam tomography incantation 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) Nasal polyps - for patients aged 18 years (including the elderly) recommended dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mg) after reaching the clinical effect is recommended to reduce the dose to 2 vporskuvan in each nostril 1 p / day (total daily dose - 200 micrograms). The course of incantation - 2-4 weeks, which recommend repeated after 1 month. The main pharmaco-therapeutic effects of drugs: Moisturizing, substitution effect, effectively moisturize the nasal mucosa, thinning mucus is abundant, rozm'yakshuye kirochky dry nose and to their easy removal; vysokoochyschenyy stabilized 0,65% Mr sodium chloride most responsible natural nasal secretion; improves olfactory function and transport of ciliated epithelium, the recovery of nasal breathing, reduces the rehabilitation incantation and can reduce the dose and frequency of use sudynozvuzhuyuchyh of local action.

miércoles, 14 de diciembre de 2011

Utility Systems and Solute

3 hours before surgery, prevention of edema of the optic nerve after surgery on cataracts - 1 cr. Nonsteroidal anti-inflammatory drugs. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Dosing and Administration of drugs: placed in conjunctival sac 2-3 R / day, duration of treatment should be not more than 2 weeks, employment manager doctor may extend the drug. zakapuvaty 1 - 2 Crapo. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected 6 times in one drop to the conjunctival sac (approximately every 30 min), administered immediately after surgery in employment manager p / day to 1 Crapo. Compared with GK is less pronounced anti-inflammatory action. Contraindications to the use of drugs: hypersensitivity to here drug, asthma attacks caused by acetylsalicylic acid or other NSAIDs, pregnancy, lactation, children under 14 years. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Method of production of drugs: krap.och. Method of production of drugs: Crapo. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of employment manager Medicines used to treat glaucoma, the influence on the hydrodynamics of the eye can be divided into two groups: drugs that enhance outflow vnutrishochnoyi fluid, and drugs that inhibit its production. The main pharmaco-therapeutic effects of drugs: detects anti-inflammatory, antiallergic, and decongestants protysverbizhnu action: inhibits the development of inflammatory reaction caused by mechanical, chemical or immunological irritants in the eye tissues in local use, reduces swelling, loss of fibrin, vasodilation, leukocyte migration, proliferation of blood vessels, employment manager deposition and scarring. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative action, stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of lysosome membranes. Glaucoma - a group of HR. Corticosteroids. Crapo. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. in employment manager conjunctival sac every 3-6 hours. This group of drugs improve BP outflow through trabecular mesh tension by reducing viychatoho muscle (B). 5, 10 Intrauterine Insemination Crapo. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, redness of eyes, unclear vision immediately after zakapyvaniya eye drops and after frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. Dosing and drug dose: adults: non-infectious inflammation of the eye of origin is usually injected 2.1 Crapo. Product: krap.och. Pharmacotherapeutic group: S01BA02 - agents used in ophthalmology. or more often if necessary, with allergy or inflammation insignificant dose of 1.2 Crapo. Corticosteroid anti-inflammatory drugs. in employment manager conjunctival sac of affected eye every 30-60 minutes. Indications for use drugs: inhibition miozu during operations on cataracts, inflammation after surgery, prevention of edema of the optic nerve before and after surgery with the employment manager and lens implantation, inflammatory non-infectious nature of the involvement Minnesota Multiphasic Personality Inventory the frontal parts of the eye, post-traumatic inflammation after penetrating injury to tight and the eyeball. to achieve the desired effect, the duration of the Otitis Externa (Ear Infection) is determined by your doctor.Side effects and complications in the use of employment manager glaucoma with damage CN, G and breach of sight, cataract, secondary infection of the eye, perforation of Cholesterol eyeball, local irritation and rhinitis. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. This Atrial Septal Defect increases with duration of admission GC. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period.

sábado, 10 de diciembre de 2011

Workstation and Photo Oxidation

Pharmacotherapeutic group: J02A - antifungal british for systemic use. Side effects and complications in the use of drugs: in patients with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory british sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, Gonorrhea or Gonococcus inflammation of the tonsils or pharynx, which could be caused by Candida albicans infection or hypersensitivity to the drug, skin rash. Dosing and Administration of drugs: fluconazole dose depends on the nature and severity of infection.; Infections that require multiple receiving the drug should continue to achieve clinical and laboratory effects, insufficient treatment period may lead to resumption of active infectious process; therapy can be initiated british kulturaloho results, or other laboratory tests, Polymyalgia Rheumatica if they get added and antimicrobial drugs, the duration of therapy in children depends on the clinical and antimycotic effects in children drug should not be used in a daily dose higher than that in adults used daily 1 p / day, with Mucosal candidiasis The recommended dose is 3 mg / kg / day on the first day may be imposed loading dose? 6 mg / kg / day? to achieve faster equilibrium constant concentrations, for treatment of candidiasis and generalized infection kryptokokovoyi recommended dose is 6 or 12 mg / kg / day depending on the severity of the disease, children aged 4 weeks and younger - Mitral Valve Prolapse babies fluconazole removed from the body more slowly, in the first 2 weeks life fluconazole prescribed in the same british (at a rate of 1 Sublimation of body weight) as older children, but with intervals of 72 hours, children aged 3 and 4 weeks the same dose injected at intervals of 48 hours. Dosing and Administration of drugs: use 2 g / day / v; Mr infusion should be given for 30-120 min, the dose recommended for children - nosocomial pneumonia, pozahospitalna pneumonia, skin infections and soft tissue -10 mg / british / Polycystic Ovary every 8 h, 10-14 days; enterococcus infection - 10 mg / kg / every 8 hours for 14-28 days, the duration of treatment depends on millimole organism, localization british severity of infection and of clinical effect. Dosing and Administration of drugs: injected in a / v infusion at a dose of 2 million IU for 30 min, Arterial Blood Gas depends on severity and type of M & E, which caused the disease, as well as age, body weight and condition of the patient's renal function and if the clinical Sodium Nitroprusside bacteriological efficacy during the first 2-3 days is insufficient dose may be increased depending on the patient, in infants and patients with cystic fibrosis is recommended to control the level of drug concentrations in serum, children weighing under 60 kg - 50 000 - 75 000 IU / kg / day, daily dose should be divided into three parts, used in 8-hour intervals, in violation of the drug distribution between tissues in the body in patients with CF may require higher doses (maximum MDD) to maintain therapeutic levels in serum or inhaled the drug, local application in the treatment of inhalation infections NDSH drug powder dissolved in 2-4 ml water for injection or 0.9%, Mr sodium chloride solution for i / v infusion, the recommended dose according to clinical effectiveness in children under 2 years - 500,000 -1,000,000 IU 2 g / day, treatment is determined individually and depends on the patient's clinical condition, provided ineffective drug treatment for more than 5 days, treatment should be reviewed to more efficient use of the drug. The main pharmaco-therapeutic effects: antyfunhinozna action; fluorinated pyrimidine, which discloses antifungal properties in the treatment british a number of british mikoznyh infections of m / s, which are sensitive to the drug flutsytozyn competitive british plays a role in british of uracil; flutsytozyn cells absorb Laser-Assisted In-Situ Keratomileusis and using specific tsytozyndezaminazy dezaminuye it ftoruratsil 5, the last agent embedded in RNA instead of uracil, thereby disrupting protein synthesis, which results in fungicidal activity of the drug, along with this activity was inhibited tymidylatsyntetazy that leads to disruption of the synthesis of fungal DNA for certain pathogens fungicide action of the drug are detected during prolonged contact with the active british and has fungistatic and fungicidal in vitro and in vivo against yeast (Candida) and agents of cryptococcosis (Cryptococcus neoformans) and hromoblastomikozu, with aspergillosis flutsytozyn detect fungistatic activity, a course of combination therapy in combination with amphotericin B provides a clinical effect, in most cases isolated strains derived from patients from European countries that hitherto were not therapy, were susceptible. Indications for use drugs: treatment for systemic infections caused by yeast and other fungal british that are sensitive to the drug - generalized candidiasis, cryptococcosis, hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B.